Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Branched evolution and genomic intratumor heterogeneity in the pathogenesis of cutaneous T-cell lymphoma

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Reduced prevalence of SARS-CoV-2 infection in ABO blood group O

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Interplay of erythropoietin, fibroblast growth factor 23, and erythroferrone in patients with hereditary hemolytic anemia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Effectiveness and safety of switching from originator to biosimilar adalimumab in patients with psoriasis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Independent evolution of cutaneous lymphoma subclones in different microenvironments of the skin

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Overall Survival in Mycosis Fungoides: A Systematic Review and Meta-Analysis

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  4. Patient-reported Outcomes During Treatment in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Aishwarya Iyer
  • Dylan Hennessey
  • Sandra O'Keefe
  • Jordan Patterson
  • Weiwei Wang
  • Gane Ka-Shu Wong
  • Robert Gniadecki
Vis graf over relationer

Mycosis fungoides (MF) is a slowly progressive cutaneous T-cell lymphoma (CTCL) for which there is no cure. In the early plaque stage, the disease is indolent, but development of tumors heralds an increased risk of metastasis and death. Previous research into the genomic landscape of CTCL revealed a complex pattern of >50 driver mutations implicated in more than a dozen signaling pathways. However, the genomic mechanisms governing disease progression and treatment resistance remain unknown. Building on our previous discovery of the clonotypic heterogeneity of MF, we hypothesized that this lymphoma does not progress in a linear fashion as currently thought but comprises heterogeneous mutational subclones. We sequenced exomes of 49 cases of MF and identified 28 previously unreported putative driver genes. MF exhibited extensive intratumoral heterogeneity (ITH) of a median of 6 subclones showing a branched phylogenetic relationship pattern. Stage progression was correlated with an increase in ITH and redistribution of mutations from stem to clades. The pattern of clonal driver mutations was highly variable, with no consistent mutations among patients. Similar intratumoral heterogeneity was detected in leukemic CTCL (Sézary syndrome). Based on these findings, we propose a model of MF pathogenesis comprising divergent evolution of cancer subclones and discuss how ITH affects the efficacy of targeted drug therapies and immunotherapies for CTCL.

OriginalsprogEngelsk
TidsskriftBlood advances
Vol/bind4
Udgave nummer11
Sider (fra-til)2489-2500
Antal sider12
ISSN2473-9529
DOI
StatusUdgivet - 9 jun. 2020

Bibliografisk note

© 2020 by The American Society of Hematology.

ID: 61800701